ReviewAnnals of medicine and surgery (2012)2025

FDA approval of imetelstat: a new era in the treatment of lower-risk myelodysplastic syndrome.

Syeda Shahnoor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.